Pulmonx Corporation
LUNG
$4.52
-$0.27-5.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -56.39M | -57.11M | -57.86M | -58.73M | -60.84M |
| Total Depreciation and Amortization | 1.49M | 1.49M | 2.33M | 1.53M | 1.55M |
| Total Amortization of Deferred Charges | 1.77M | 1.77M | 973.00K | 54.00K | 48.00K |
| Total Other Non-Cash Items | 23.30M | 23.51M | 24.69M | 24.98M | 24.20M |
| Change in Net Operating Assets | -1.70M | -2.91M | -4.76M | -4.59M | -2.56M |
| Cash from Operations | -31.54M | -33.26M | -34.64M | -36.76M | -37.61M |
| Capital Expenditure | -1.45M | -1.54M | -1.61M | -1.20M | -807.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.92M | 2.19M | -3.50M | -3.89M | -1.20M |
| Cash from Investing | 17.48M | 654.00K | -5.11M | -5.09M | -2.01M |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 20.00M |
| Total Debt Repaid | -95.00K | -93.00K | -93.00K | -94.00K | -94.00K |
| Issuance of Common Stock | 1.46M | 1.41M | 1.52M | 1.64M | 1.49M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.36M | 1.32M | 1.43M | 1.54M | 21.40M |
| Foreign Exchange rate Adjustments | 76.00K | -327.00K | -6.00K | 61.00K | 34.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.62M | -31.61M | -38.33M | -40.24M | -18.18M |